Thus, while both serpins have anti-plasminogen activation activity, and loss or gain of PAI-2 expression has been shown in a cancer context-specific manner to be associated with worse or improved outcomes, respectively [11]; the clinical data showing that increased PAI-1 expression is strongly correlated with poor cancer outcome is highly convincing [47]. Here, SERPINE1 is linked to cancer.